Issels Integrative Immuno-Oncology March 24, 2016  

Should Your Family Consider Genetic Testing for Cancer?

Dear Friend,

Oscar-winning actress Angelina Jolie raised public awareness of genetic testing for cancer. Her mother died at the age of 56 after a lengthy battle with cancer, and Ms. Jolie subsequently discovered she carries a gene mutation that is a marker for increased risk of breast and ovarian cancer.

Our non-toxic immunotherapy program takes genetic predisposition toward cancer into account as part of our personalized treatments. Do you have a family history of cancer? Here is what you should know about genetic testing for cancer.

Family history review

Your doctor will begin by constructing a family tree and noting any incidence of cancer to determine possible pattern. In addition to breast, uterine and ovarian cancer, pancreatic cancer is another form that is often linked to a single mutation.

Assessment and testing

Once the family tree is complete, a determination will be made as to your personal risk of developing cancer. It's estimated that between five and 15 percent of cancers are hereditary, but an increased risk is not a guarantee that cancer will develop. Based on the results of the assessment, your doctor may recommend genetic testing.

Emotional impact

Any consideration of a serious illness such as cancer will bring up a number of emotions. The genetic testing process includes counseling to help patients deal with the anxiety, guilt and other feelings that may arise.

Your family history, lifestyle and environment are some of the personal factors used to develop our individualized non-toxic immunotherapy program. Visit our website for more information about Issels® and our comprehensive integrative cancer treatment therapies.

Should Your Family Do Genetic Testing for Cancer?

Read more interesting articles on the "Issels Integrative Immuno-Oncology" news/blog posted every Tuesday and Thursday. Check It Out Now »

"Angelina" Effect Causes More to Consider Genetic Testing

Angelina Jolie's disclosures have raised awareness of hereditary breast cancer, prompting more women to undergo genetic testing for the BRCA1 and BRCA2 gene mutations.

However, in the latest cancer news, some major insurance companies are refusing to cover the costs of this testing. These companies, which include Aetna and Cigna, won't cover these costs out of concern that the tests are unproven and might end up causing patients to seek unnecessary medical care, such as preventive chemotherapy.

Get the Full Story!

Genetic Mutation Linked to Prostate Cancer May Lead to New Treatments

Researchers took samples from 5,100 prostate cancer patients who were 55 years old or younger (94 families represented) and 1,400 healthy men. After sequencing more than 200 genes, they found the following:

• 72 men in four families carried the same HOXB13 gene mutation.

• Only one man in the control group had the mutation.

Find out more about these interesting findings.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us